ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,198,860 | -12.0% | 412,633 | -0.3% | 1.98% | -10.2% |
| Q2 2023 | $12,720,673 | +157.4% | 413,815 | +201.7% | 2.20% | +148.0% |
| Q1 2023 | $4,942,307 | -9.0% | 137,172 | -0.1% | 0.89% | -9.3% |
| Q4 2022 | $5,428,902 | -2.8% | 137,371 | -1.2% | 0.98% | -12.1% |
| Q3 2022 | $5,586,000 | -4.4% | 139,024 | +0.0% | 1.11% | -0.2% |
| Q2 2022 | $5,844,000 | +13.6% | 139,012 | +5.3% | 1.12% | +35.2% |
| Q1 2022 | $5,145,000 | -6.4% | 132,070 | -4.3% | 0.82% | +1.7% |
| Q4 2021 | $5,497,000 | – | 137,941 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |